Frederico Monzon and Greg Schafer
Castle Biosciences has appointed Frederico Monson as chief financial officer and Greg Schafer as executive director of managed care. Monson most recently served as medical director of Oncology and medical director of Latin America at Invitae. Previously, he served in several successive roles at Baylor College of Medicine, including director of pathology at its Cancer Genetics Laboratory. Schafer most recently served as head of managed care at Invitae. Previously, he served as director of strategic markets and associate director of managed care at Genomic Health. Earlier in his career, Schafer served as business relations manager at Biogen and held sales management roles at Novartis and Zeneca Pharmaceuticals.